chartexchange

UNCY Deadline: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights

Business Wire | Oct 27, 2026 4:30 PM EDT

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29, 2025 and June 29, 2026. Unicycive describes itself as a “clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767

Read original article